Lactobacillus acidophilus Alleviates Platelet-Activating Factor-Induced Inflammatory Responses in Human Intestinal Epithelial Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Borthakur, Alip ^a   Bhattacharyya, Sumit ^a   Kumar, Anoop ^a   Anbazhagan, Arivarasu Natarajan ^a   Tobacman, Joanne K ^a   Dudeja, Pradeep K ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; PROBIOTIC AGENT; PROTEIN BCL 10; PROTEIN CARMA3; PROTEIN MALT1; SYNAPTOTAGMIN I; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFICACY; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE EPITHELIUM CELL; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PROMOTER REGION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SUPERNATANT; UBIQUITINATION;

CACO-2 CELLS; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-8; INTESTINES; LACTOBACILLUS ACIDOPHILUS; NF-KAPPA B; PLATELET ACTIVATING FACTOR;

EID: 84885156450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075664     Document Type: Article

References (50)

1. Kaur N, Chen CC, Luther J, Kao JY, (2011) Intestinal dysbiosis in inflammatory bowel disease. Gut Microbes 2: 211-216.
2. Wu GD, Bushmanc FD, Lewis JD (2013) Diet, the human gut microbiota, and IBD. Anaerobe. Epub ahead of print.
3. Grishin A, Papillon S, Bell B, Wang J, Ford HR, (2013) The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 22: 69-75.
4. Carlisle EM, Morowitz MJ, (2013) The intestinal microbiome and necrotizing enterocolitis. Curr Opin Pediatr 25: 382-387.
5. Magrone T, Jirillo E, (2013) The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. Curr Pharm Des 19: 1329-1342.
6. Whelan K, Quigley EM, (2013) Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 29: 184-189.
7. Nissen L, Chingwaru W, Sgorbati B, Biavati B, Cencic A, (2009) Gut health promoting activity of new putative probiotic/protective Lactobacillus spp. strains: a functional study in the small intestinal cell model. Int J Food Microbiol 135: 288-294.
8. Xu LF, Teng X, Guo J, Sun M, (2012) Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. Inflammation 35: 308-315.
9. Kald B, Olaison G, Sjodahl R, Tagesson C, (1990) Novel aspect of Crohn's disease: increased content of platelet-activating factor in ileal and colonic mucosa. Digestion 46: 199-204.
10. Sobhani I, Hochlaf S, Denizot Y, Vissuzaine C, Rene E, et al. (1992) Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. Gut 33: 1220-1225.
11. Hsueh W, Caplan MS, Sun X, Tan X, MacKendrick W, et al. (1994) Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis. Acta Paediatr Suppl 396: 11-17.
12. Frost BL, Jilling T, Caplan MS, (2008) The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis. Semin Perinatol 32: 100-106.
13. Egea L, Gimenez R, Lucia D, Modolell I, Badia J, et al. (2008) Increased production of the ether-lipid platelet-activating factor in intestinal epithelial cells infected by Salmonella enteritidis. Biochim Biophys Acta 1781: 270-276.
14. Merendino N, Dwinell MB, Varki N, Eckmann L, Kagnoff MF, (1999) Human intestinal epithelial cells express receptors for platelet-activating factor. Am J Physiol 277: G810-818.
15. Im SY, Han SJ, Ko HM, Choi JH, Chun SB, et al. (1997) Involvement of nuclear factor-kappa B in platelet-activating factor-mediated tumor necrosis factor-alpha expression. Eur J Immunol 27: 2800-2804.
16. Han SJ, Choi JH, Ko HM, Yang HW, Choi IW, et al. (1999) Glucocorticoids prevent NF-kappaB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. Eur J Immunol 29: 1334-1341.
17. Venkatesha RT, Ahamed J, Nuesch C, Zaidi AK, Ali H, (2004) Platelet-activating factor-induced chemokine gene expression requires NF-kappaB activation and Ca2+/calcineurin signaling pathways. Inhibition by receptor phosphorylation and beta-arrestin recruitment. J Biol Chem 279: 44606-44612.
18. Choi JH, Ko HM, Kim JW, Lee HK, Han SS, et al. (2001) Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans. J Immunol 166: 5139-5144.
19. Hayden MS, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
20. Oeckinghaus A, Hayden MS, Ghosh S, (2011) Crosstalk in NF-kappaB signaling pathways. Nat Immunol 12: 695-708.
21. Jiang C, Lin X, (2012) Regulation of NF-kappaB by the CARD proteins. Immunol Rev 246: 141-153.
22. Rosebeck S, Rehman AO, Lucas PC, McAllister-Lucas LM, (2011) From MALT lymphoma to the CBM signalosome: three decades of discovery. Cell Cycle 10: 2485-2496.
23. Lucas PC, McAllister-Lucas LM, Nunez G, (2004) NF-kappaB signaling in lymphocytes: a new cast of characters. J Cell Sci 117: 31-39.
24. Borthakur A, Bhattacharyya S, Alrefai WA, Tobacman JK, Ramaswamy K, et al. (2010) Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. Inflamm Bowel Dis 16: 593-603.
25. Borthakur A, Bhattacharyya S, Dudeja PK, Tobacman JK, (2007) Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292: G829-838.
26. Bhattacharyya S, Borthakur A, Tyagi S, Gill R, Chen ML, et al. (2010) B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation. J Biol Chem 285: 522-530.
27. Yang YJ, Chuang CC, Yang HB, Lu CC, Sheu BS, (2012) Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFkappaB pathways. BMC Microbiol 12: 38.
28. Dai C, Zheng CQ, Meng FJ, Zhou Z, Sang LX, et al. (2013) VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-kappaB pathway in rat model of DSS-induced colitis. Mol Cell Biochem 374: 1-11.
29. Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, et al. (2004) Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427: 167-171.
30. Frost BL, Caplan MS, (2013) Necrotizing enterocolitis: pathophysiology, platelet-activating factor, and probiotics. Semin Pediatr Surg 22: 88-93.
31. Ganguli K, Walker WA, (2012) Treatment of necrotizing enterocolitis with probiotics. Gastroenterol Clin North Am 41: 733-746.
32. Jonkers D, Penders J, Masclee A, Pierik M, (2012) Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs 72: 803-823.
33. Veerappan GR, Betteridge J, Young PE, (2012) Probiotics for the treatment of inflammatory bowel disease. Curr Gastroenterol Rep 14: 324-333.
34. Borman RA, Jewell R, Hillier K, (1998) Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro. Br J Pharmacol 123: 231-236.
35. Claud EC, Lu J, Wang XQ, Abe M, Petrof EO, et al. (2008) Platelet-activating factor-induced chloride channel activation is associated with intracellular acidosis and apoptosis of intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 294: G1191-1200.
36. Chao W, Liu H, Hanahan DJ, Olson MS, (1992) Platelet-activating factor-stimulated protein tyrosine phosphorylation and eicosanoid synthesis in rat Kupffer cells. Evidence for calcium-dependent and protein kinase C-dependent and-independent pathways. J Biol Chem 267: 6725-6735.
37. Chao W, Olson MS, (1993) Platelet-activating factor: receptors and signal transduction. Biochem J 292 (Pt 3): 617-629.
38. De Plaen IG, Tan XD, Chang H, Qu XW, Liu QP, et al. (1998) Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor. Biochim Biophys Acta 1392: 185-192.
39. Lu J, Caplan MS, Li D, Jilling T, (2008) Polyunsaturated fatty acids block platelet-activating factor-induced phosphatidylinositol 3 kinase/Akt-mediated apoptosis in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 294: G1181-1190.
40. Roth M, Nauck M, Yousefi S, Tamm M, Blaser K, et al. (1996) Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J Exp Med 184: 191-201.
41. Nasu K, Narahara H, Matsui N, Kawano Y, Tanaka Y, et al. (1999) Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. Mol Hum Reprod 5: 548-553.
42. Sun J, (2010) CARMA3: A novel scaffold protein in regulation of NF-kappaB activation and diseases. World J Biol Chem 1: 353-361.
43. Borthakur A, Gill RK, Tyagi S, Koutsouris A, Alrefai WA, et al. (2008) The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells. J Nutr 138: 1355-1359.
44. Singh V, Raheja G, Borthakur A, Kumar A, Gill RK, et al. (2012) Lactobacillus acidophilus upregulates intestinal NHE3 expression and function. Am J Physiol Gastrointest Liver Physiol 303: G1393-1401.
45. Tao Y, Drabik KA, Waypa TS, Musch MW, Alverdy JC, et al. (2006) Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 290: C1018-1030.
46. Petrof EO, Claud EC, Sun J, Abramova T, Guo Y, et al. (2009) Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function. Inflamm Bowel Dis 15: 1537-1547.
47. Segawa S, Fujiya M, Konishi H, Ueno N, Kobayashi N, et al. (2011) Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway. PLoS One 6: e23278.
48. Howarth GS, Wang H, (2013) Role of endogenous microbiota, probiotics and their biological products in human health. Nutrients 5: 58-81.
49. Gautheron J, Courtois G, (2010) "Without Ub I am nothing": NEMO as a multifunctional player in ubiquitin-mediated control of NF-kappaB activation. Cell Mol Life Sci 67: 3101-3113.
50. Bhattacharyya S, Pant N, Dudeja PK, Tobacman JK, (2007) Development, evaluation, and application of a highly sensitive microtiter plate ELISA for human Bcl10 protein. J Immunoassay Immunochem 28: 173-188.